2553 related articles for article (PubMed ID: 18851928)
1. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.
Dalmau J; Tüzün E; Wu HY; Masjuan J; Rossi JE; Voloschin A; Baehring JM; Shimazaki H; Koide R; King D; Mason W; Sansing LH; Dichter MA; Rosenfeld MR; Lynch DR
Ann Neurol; 2007 Jan; 61(1):25-36. PubMed ID: 17262855
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
Irani SR; Bera K; Waters P; Zuliani L; Maxwell S; Zandi MS; Friese MA; Galea I; Kullmann DM; Beeson D; Lang B; Bien CG; Vincent A
Brain; 2010 Jun; 133(Pt 6):1655-67. PubMed ID: 20511282
[TBL] [Abstract][Full Text] [Related]
4. Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults.
Vincent A; Bien CG
Lancet Neurol; 2008 Dec; 7(12):1074-5. PubMed ID: 18851929
[No Abstract] [Full Text] [Related]
5. [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology].
Iizuka T; Sakai F
Brain Nerve; 2008 Sep; 60(9):1047-60. PubMed ID: 18807939
[TBL] [Abstract][Full Text] [Related]
6. [Psychiatric symptoms of a paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis: A case report].
Le Foll J; Pelletier A
Encephale; 2010 Apr; 36(2):166-71. PubMed ID: 20434635
[TBL] [Abstract][Full Text] [Related]
7. [Anti-NMDA receptor paraneoplastic encephalitis: complete recovery after ovarian teratoma removal].
Reyes-Botero G; Uribe CS; Hernandez-Ortiz OE; Ciro J; Guerra A; Dalmau-Obrador J
Rev Neurol; 2011 May; 52(9):536-40. PubMed ID: 21484725
[TBL] [Abstract][Full Text] [Related]
8. [Anti-NMDA receptor antibody-mediated encephalitis/encephalopathy].
Iizuka T; Hara A
Rinsho Byori; 2009 Mar; 57(3):252-61. PubMed ID: 19363996
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features and pathogenesis of anti-NMDA receptor encephalitis].
Iizuka T
Rinsho Shinkeigaku; 2008 Nov; 48(11):920-2. PubMed ID: 19198118
[TBL] [Abstract][Full Text] [Related]
10. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.
Iizuka T; Sakai F; Ide T; Monzen T; Yoshii S; Iigaya M; Suzuki K; Lynch DR; Suzuki N; Hata T; Dalmau J
Neurology; 2008 Feb; 70(7):504-11. PubMed ID: 17898324
[TBL] [Abstract][Full Text] [Related]
11. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis.
Seki M; Suzuki S; Iizuka T; Shimizu T; Nihei Y; Suzuki N; Dalmau J
J Neurol Neurosurg Psychiatry; 2008 Mar; 79(3):324-6. PubMed ID: 18032452
[TBL] [Abstract][Full Text] [Related]
12. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
13. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
Gresa-Arribas N; Titulaer MJ; Torrents A; Aguilar E; McCracken L; Leypoldt F; Gleichman AJ; Balice-Gordon R; Rosenfeld MR; Lynch D; Graus F; Dalmau J
Lancet Neurol; 2014 Feb; 13(2):167-77. PubMed ID: 24360484
[TBL] [Abstract][Full Text] [Related]
14. Anti-N-methyl-D-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-up.
Xu CL; Liu L; Zhao WQ; Li JM; Wang RJ; Wang SH; Wang DX; Liu MY; Qiao SS; Wang JW
BMC Neurol; 2011 Nov; 11():149. PubMed ID: 22126669
[TBL] [Abstract][Full Text] [Related]
15. Anti-N-methyl-D-aspartate receptor encephalitis associated with an ovarian teratoma in an adolescent female.
Lesher AP; Myers TJ; Tecklenburg F; Streck CJ
J Pediatr Surg; 2010 Jul; 45(7):1550-3. PubMed ID: 20638543
[TBL] [Abstract][Full Text] [Related]
16. [Unique clinical features and pathophysiology of anti-NMDA receptor encephalitis].
Iizuka T
Rinsho Shinkeigaku; 2009 Nov; 49(11):774-8. PubMed ID: 20030207
[TBL] [Abstract][Full Text] [Related]
17. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.
Petit-Pedrol M; Armangue T; Peng X; Bataller L; Cellucci T; Davis R; McCracken L; Martinez-Hernandez E; Mason WP; Kruer MC; Ritacco DG; Grisold W; Meaney BF; Alcalá C; Sillevis-Smitt P; Titulaer MJ; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2014 Mar; 13(3):276-86. PubMed ID: 24462240
[TBL] [Abstract][Full Text] [Related]
18. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.
Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L
Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902
[TBL] [Abstract][Full Text] [Related]
19. [Recent topics on paraneoplastic neurological syndromes: anti-NMDA antibody].
Koide R
Nihon Naika Gakkai Zasshi; 2008 Aug; 97(8):1851-4. PubMed ID: 18833707
[No Abstract] [Full Text] [Related]
20. Anti-NMDAR autoimmune encephalitis.
Miya K; Takahashi Y; Mori H
Brain Dev; 2014 Sep; 36(8):645-52. PubMed ID: 24211006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
